文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

奥利西定与芬太尼术中镇痛对行腹腔镜胆囊切除术女性患者术后恶心呕吐影响的比较:一项随机双盲对照试验的研究方案

Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial.
PubMed 文献 · Trials · 2025-12-08

本研究为在中国常熟市第二人民医院开展的单中心随机对照试验,计划纳入228例择期行腹腔镜胆囊切除术的女性患者,按1:1随机接受奥利西定(O组)或芬太尼(F组)术中镇痛。主要终点为术后24小时内恶心呕吐发生率,次要终点包括恶心呕吐严重程度、首次发生时间、止吐药与补救镇痛需求、术后疼痛评估、首次排气与拔管时间、术后睡眠质量、术中麻醉药与血管升压药用量及围术期不良事件。作者假设奥利西定可能提供有效镇痛且恶心呕吐发生率低于芬太尼。

要点

  • 计划纳入228例择期腹腔镜胆囊切除术女性患者,1:1随机接受奥利西定或芬太尼术中镇痛。
  • 主要终点为术后24小时内恶心呕吐发生率。
  • 作者假设奥利西定可能提供有效镇痛且术后恶心呕吐发生率低于芬太尼。

核心结论

  • 作者假设奥利西定可能为腹腔镜胆囊切除术女性患者提供有效镇痛且术后恶心呕吐发生率低于芬太尼。
  • 研究结果可能为优化围术期疼痛管理策略和促进患者康复提供有价值的信息。

研究设计与样本

  • 单中心随机对照试验,在中国常熟市第二人民医院开展。
  • 计划纳入228例择期行腹腔镜胆囊切除术的女性患者,按1:1比例随机分配接受奥利西定(O组)或芬太尼(F组)术中镇痛。

主要发现

  • 主要终点为术后24小时内恶心呕吐发生率。
  • 次要终点包括恶心呕吐严重程度与首次发生时间、止吐药与补救镇痛需求、术后疼痛评估、首次排气与拔管时间、术后睡眠质量、术中麻醉药与血管升压药用量及围术期不良事件。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative nausea and vomiting (PONV) is significantly associated with intraoperative opioid use. Oliceridine, a μ-opioid receptor agonist with G protein bias, exhibits fewer opioid-related adverse events (ORAEs) than morphine. This study aims to evaluate the effect of oliceridine versus fentanyl on the incidence of PONV in female patients undergoing laparoscopic cholecystectomy. METHODS: This is a single-center, randomized controlled trial conducted at Changshu No. 2 People's Hospital in China. A total of 228 female patients scheduled for elective laparoscopic cholecystectomy will be enrolled in this trial and randomly assigned in a 1:1 ratio to receive either oliceridine (Group O) or fentanyl (Group F) for intraoperative analgesia. The primary endpoint is the incidence of PONV during the first 24 h postoperatively. The secondary endpoints consist of the severity and timing of the initial occurrence of PONV, the requirement for antiemetics and rescue analgesia, postoperative pain assessments, time to first flatus and extubation, postoperative sleep quality, intraoperative consumption of anesthetics and vasopressors, and perioperative adverse effects. DISCUSSION: We hypothesize that oliceridine may offer effective analgesia and a lower incidence of PONV than fentanyl in intraoperative pain management for this high-risk group. The findings may provide valuable insights into optimizing perioperative pain management strategies and enhancing patient recovery. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2500096538. Registered on 26 January 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Xu F, Cui Y, Wang Z, et al. Comparison of oliceridine and fentanyl intraoperative analgesia on postoperative nausea and vomiting in female patients undergoing laparoscopic cholecystectomy: study protocol for a randomized, double-blind, controlled trial. Trials. 2025. PMID: 41361891. doi:10.1186/s13063-025-09336-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。